J M Wenzlau

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. ncbi Development of a novel autoantibody assay for autoimmune gastritis in type 1 diabetic individuals
    J M Wenzlau
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
    Diabetes Metab Res Rev 27:887-90. 2011
  2. ncbi Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects
    J M Wenzlau
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 95:4712-9. 2010
  3. ncbi Conserved epitopes in the protein tyrosine phosphatase family of diabetes autoantigens
    Y Liu
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
    Ann N Y Acad Sci 1150:245-7. 2008

Collaborators

Detail Information

Publications3

  1. ncbi Development of a novel autoantibody assay for autoimmune gastritis in type 1 diabetic individuals
    J M Wenzlau
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
    Diabetes Metab Res Rev 27:887-90. 2011
    ..Parietal cell autoantibody detection via enzyme-linked immunosorbent assay is currently the most widely used biomarker of disease with diagnosis confirmed by subsequent immunohistochemistry via biopsy...
  2. ncbi Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects
    J M Wenzlau
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045, USA
    J Clin Endocrinol Metab 95:4712-9. 2010
    ..Zinc transporter 8 (ZnT8) is a newly discovered islet autoantigen in human type 1A diabetes (T1D)...
  3. ncbi Conserved epitopes in the protein tyrosine phosphatase family of diabetes autoantigens
    Y Liu
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
    Ann N Y Acad Sci 1150:245-7. 2008
    ..1% to FLYDA, and 33.7% to IDA. The majority of sera that bound FLYDA and/or IDA also recognized IA2. This raises the possibility that in some cases reactivity to IA2 may have arisen by molecular mimicry...